For two decades, all it took for an English minor in order to get a prescription for puberty blockers and/or genital surgery at the Tavistock Clinic, was for him or her to identify as a gender different from his biological sex. Meanwhile, those who found this practice dangerous were prosecuted for transphobia [2] [3] [4].
Source: Nicole Delépine
In Great Britain, the serious consequences of this policy were revealed by Keira Bell’s[5] legal complaint[6] [7], publicised by courageous journalists[8] and perfectly analysed in the study by Dr Cass[9] commissioned by the National Health Service (NHS). Since then, the NHS has been implementing the measures recommended in her review, which are well worth repeating.
Some conclusions from the Cass review
The review totally contradicts the information that the World Professional Association for Transgender Health (WPATH), clinicians and pro-transgender activists were giving to children and their parents.
The NHS had ignored the evidence-based health care that all patients have the right to expect when dealing with minors suffering from gender-dysphoria.
The gender care services did not keep adequate data on the children they treated, or on their outcomes, so it is impossible to know the extent of the harm caused to them.
Many adolescents considered to have gender dysphoria suffer from mental disorders and neurocognitive difficulties, making it difficult to predict the development of their gender identity.
It is surprising that the medical authorities ignored these abuses for decades.
It is scandalous that certain adults’ beliefs have allowed them to decide on healthcare for children, and incomprehensible that pro-transgender campaigners from outside the NHS have had so much influence on these practices.
Only by learning from these mistakes can another health scandal be avoided.
The diagnosis of “gender” must no longer be based on the mere “affirmation” of a feeling.
The diagnosis of gender dysphoria requires a global medical approach to the development of sexual identity in children.
The assertion by the person concerned of a malaise that he attributes to his sexual identity is no longer sufficient for a diagnosis of gender dysphoria, but merely constitutes the symptom of a malaise that needs to be analysed medically.
The new guidelines state that ” assessments should be respectful of the child or young person’s experience and take account of their development”.
Social transition is not recommended for minors
Social transition consists of identifying oneself as a gender different from one’s sex, both in relationships with others (by asking to be called by a new first name of the opposite sex) and in administrative formalities.
The new NHS guidelines regard social transition as a psychosocial intervention that can have a significant impact on psychological functioning.
The NHS strongly advises against it in children, stating that it should only be undertaken to alleviate or prevent clinically significant distress or significant impairment of social functioning, and that it should always be preceded by an explicit informed consent process.
Psychotherapy: the preferred treatment
All young people suffering from gender dysphoria will first be treated with developmentally-oriented psychotherapy and psycho-education, taking into account a wide range of pathologies in addition to gender dysphoria.
For those wishing to undertake medical treatment, eligibility will be determined by a centralised service, on the recommendation of a GP or other NHS provider.
Hormonal treatments should only be prescribed in the context of clinical trials.
The World Professional Association for Transgender Health and the pro-transgender lobbies had imposed the credo that young people suffering from gender dysphoria would benefit from “transgender healthcare” involving puberty blockers and/or cross-reactive hormones.
This scientifically unfounded hypothesis is rejected by the NHS, which now advocates a medical approach tailored to the person’s specific needs following careful therapeutic exploration and ” may require a focus on managing other clinical needs and risks in collaboration with a local network of service providers”.
The medium- and long-term effects of puberty blockers are unknown in healthy subjects, and will from now on only be supplied in the context of formal, well-structured research protocols that have been reviewed by ethics committees.
All minors being considered for hormone treatment will be enrolled in a prospective research study in order to learn more about the effects of hormonal interventions, and to make an international contribution to this field of medicine.
The studies must follow the minors at least until they reach adulthood.
Treatment can only be discussed in cases of proven “gender dysphoria” .
The NHS emphasises the distinction between the diagnosis of “gender incongruence”, which is not necessarily associated with distress, and the diagnosis of “gender dysphoria”, which is characterised by significant distress and/or functional impairments.
Treatment should only be considered in cases of “gender dysphoria”.
Gender incongruence is not based on clinical treatment objectives, beyond the individual’s desire to align their body with their internal vision of their gender identity.
The new NHS guidelines therefore represent a complete rejection of the approach taken over the last decade to the management of minors suffering from gender dysphoria.
France still lagging behind
In France, affirmative transgender ideology still dominates practice[10] [11]Minors can decide their own gender and demand to be called by a different name by their classmates and teacher without any prior medical or psychiatric examination, or any discussion of the problem in class with other pupils who may be offended by it. And anyone who refuses to do so and expresses their concerns is easily accused of transphobia in the media and prosecuted[12].
And although the French Academy of Medicine has expressed reservations about medical treatments for minors, these are still authorised and are not reserved for strictly supervised trials.
How much longer will such a situation, which is contrary to current scientific evidence from the UK, Sweden and Norway and dangerous for minors, be tolerated?
It is to be hoped that the next meeting of the National Assembly will validate the law that the Republican senators have drawn up to protect our children from the excesses of a harmful ideology benefiting from media propaganda that only serves the interests of certain pharmaceutical laboratories and certain surgeons and other health or “wellness” professionals likely to benefit from it (hair removal, etc).
[1] Gender dysphoria by N and G Delepine Fauves éditions 2023
Gender dysphoria N et G Delépine in english fauves éditions 2024
[2] https://www.lefigaro.fr/actualite-france/katheen-stock-lesbienne-et-militante-feministe-derniere-victime-du-wokisme-britannique-20211106
[3]https://etudiant.lefigaro.fr/article/accuses-de-transphobie-200-universitaires-britanniques-denoncent-les-intimidations-de-militants-woke-et-la-complicite-des-universites_c00b8ef6-2f4b-11ec-a72f-84311d091266/
[4] https://www.gov.uk/guidance/equality-act-2010-guidance
[5] https://www.persuasion.community/p/keira-bell-my-story
[6] High Court of Justice, 1/12/2020, Quincy Bell ans A v. Tavistock and Portman NHS Trust and others, 2020 EWHC 3274https://www.judiciary.uk/judgments/r-on-the-application-of-quincy-bell-and-a-v-tavistock-and-portman-nhs-trust-and-others/
[7]https://www.judiciary.uk/wp-content/uploads/2020/12/Bell-v-Tavistock-Judgment.pdf
[8]https://segm.org/GIDS-puberty-blockers-minors-the-times-special-report
[9] https://cass.independent-review.uk/home/publications/final-report/
[10] Gender ideology, the Trojan horse of wokism and transhumanism – Dr Nicole Delépine (nicoledelepine.fr)
[11][11] Gender dysphoria & transmania: medical/societal aspects | Mondialisation – Centre de Recherche sur la Mondialisation